OraSure Technologies Inc. (OSUR)

AI Score

Unlock

3.40

-0.09 (-2.58%)

At close: Mar 28, 2025, 11:53 AM

-2.58% (1D)

Bid	3.33
Market Cap	253.95M
Revenue (ttm)	109.06M
Net Income (ttm)	-8.74M
EPS (ttm)	-0.26
PE Ratio (ttm)	-13.06
Forward PE	-650.58
Analyst	Hold

Ask	3.48
Volume	147,651
Avg. Volume (20D)	883,960
Open	3.47
Previous Close	3.49
Day's Range	3.39 - 3.48
52-Week Range	2.69 - 6.35
Beta	-0.02

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Nov 17, 1986

Employees 501

Stock Exchange NASDAQ

Ticker Symbol OSUR

Website https://www.orasure.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 62.00% from the latest price.

Stock Forecasts

Next Earnings Release

OraSure Technologies Inc. is scheduled to release its earnings on May 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 days ago

+6.4%

OraSure Technologies shares are trading higher aft... Unlock content with Pro Subscription

1 month ago

-23.5%

OraSure Technologies shares are trading lower after the company issued Q1 revenue guidance below estimates.

News

4 weeks ago · seekingalpha.com

OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript

OraSure Technologies, Inc. (NASDAQ:OSUR ) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President ...

1 month ago · zacks.com

OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates

OraSure Technologies (OSUR) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.22 per share a year ago.

2 months ago · zacks.com

OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?

OraSure (OSUR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · zacks.com

New Strong Buy Stocks for January 27th

ALNY, HBT, APH, GNTY and OSUR have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2024.

2 months ago · zacks.com

Should Value Investors Buy OraSure Technologies (OSUR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...